Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

CLOZARIL

CLOZAPINE

Standard Dose
25MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Prescription
Summary

Approval overview CLOZARIL is listed in Drugs@FDA under application 019758 (NDA).

Review priority: N/A Marketing status: Prescription Active ingredient CLOZAPINE Form and strength TABLET;ORAL - 25MG Sponsor HERITAGE LIFE Submission history Latest submission status date: 2025-06-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview CLOZARIL is listed in Drugs@FDA under application 019758 (NDA). Review priority: N/A Marketing status: Prescription Active ingredient CLOZAPINE Form and strength TABLET;ORAL - 25MG Sponsor HERITAGE LIFE Submission history Latest submission status date: 2025-06-13 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: N/A

Interaction Notes

  • No interaction notes stored yet.